title: A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus.
authors.forename: S K
authors.initials: SK
authors.lastname: Thondam
authors.forename: D J
authors.initials: DJ
authors.lastname: Cuthbertson
authors.forename: B S
authors.initials: BS
authors.lastname: Aditya
authors.forename: I A
authors.initials: IA
authors.lastname: Macfarlane
authors.forename: J P
authors.initials: JP
authors.lastname: Wilding
authors.forename: C
authors.initials: C
authors.lastname: Daousi
mesh_terms: D002648:Child; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D000077270:Exenatide; D005260:Female; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism; D010455:Peptides / Q000627:therapeutic use; D018027:Receptors, Glucagon / Q000819:agonists* / Q000378:metabolism*; D014688:Venoms / Q000627:therapeutic use
chemical_list: C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D010455:Peptides; D018027:Receptors, Glucagon; D014688:Venoms; D000077270:Exenatide